Overview
Hans-erik Lundgren practices in Umea, Sweden. Lundgren is rated as an Advanced expert by MediFind in the treatment of Transthyretin Amyloidosis. Their top areas of expertise are Transthyretin Amyloidosis, Familial Transthyretin Amyloidosis, Cardiac Amyloidosis, and Primary Amyloidosis.
Their clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Transthyretin Amyloidosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Transthyretin Amyloidosis
- Transthyretin AmyloidosisLundgren isAdvanced. Learn about Transthyretin Amyloidosis.
- Experienced
- Cardiac AmyloidosisLundgren isExperienced. Learn about Cardiac Amyloidosis.
- CardiomyopathyLundgren isExperienced. Learn about Cardiomyopathy.
- Primary AmyloidosisLundgren isExperienced. Learn about Primary Amyloidosis.